Sudan and Djibouti are the first ERM beneficiaries from HIV/AIDS treatment initiative.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D019468:Disease Management; D015730:Djibouti / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy*; D006297:Health Services Accessibility; D006801:Humans; D013397:Sudan / Q000453:epidemiology; D014944:World Health Organization
D044966:Anti-Retroviral Agents